Search results
Results from the WOW.Com Content Network
Colin Farrell reveals son's Angelman syndrome diagnosis. Colin Farrell, an Oscar-nominated actor, has launched the Colin Farrell Foundation, which is "committed to transforming the lives of ...
Ultragenyx Pharmaceutical Inc. is an American biopharmaceutical company involved in the research and development of novel products for treatment of rare and ultra-rare genetic diseases for which there are typically no approved treatments and high unmet medical need.
Angelman syndrome is a rare, incurable neurogenetic disorder that can cause intellectual disability, speech and balance problems, developmental delays and possible seizures, according to the Mayo ...
Kenneth Blum (born August 8, 1939) is an American scientist who has studied neuropsychopharmacology and genetics.Until 1995 he was a professor of pharmacology at the University of Texas Health Science Center at San Antonio.
The Foundation also paid some employees from Soon-Shiong's companies, which is a potentially inappropriate use of charitable funds to cover unrelated business overhead. [ 27 ] The foundation contributed a quarter of a $12 million donation by Soon-Shiong-controlled organizations to the University of Utah to set up a gene mapping project.
At the core of Farrell's new organization and its mission: the actor's 20-year-old son James, who lives with Angelman Syndrome. "I want the world to be kind to James," Farrell told People in an ...
Diagnostic criteria for the disorder were initially established in 1995 in collaboration with the Angelman syndrome Foundation (US); [26] these criteria underwent revision in 2005. [ 27 ] Seizures are a consequence, as is excessive laughter, [ 28 ] which is a major hindrance to early diagnosis.
For premium support please call: 800-290-4726 more ways to reach us